Skip to main content

Table 1 Proteins identified by mass spectrometry after separation with PEP technology and Hexokinase Activity Analysis

From: Identification of functional metabolic biomarkers from lung cancer patient serum using PEP technology

Sample number Sample location in PEP plate Tentative protein ID
Sample-1 N19A Plasminogen (PLG)
Sample-2 N7B, N8B Hemopexin (HPX)
Sample-3 N22H, N23H, N22I Complement Component 3 (C3)
Sample-4 N17J, N18J Fatty Acid Synthase (FASN)
Sample-5 N18K, N19K Glyceraldehyde-3-phosphate Dehydrogenase (GAPDH)
Sample-6 N10M, N11M Fatty Acid Synthase (FASN)
Sample-7 N15M, N16M Enolase 1 (ENO1)
Sample-8 N1P, N2P, N3P Glyceralde-3-phosphate Dehydrogenase
Sample-9 N10P, N11P Alpha-2-glycoprotein 1 (AZGP1)
Sample-10 C3A Fatty Acid Synthase (FASN)
Sample-11 C9A, C9B Glyceraldehyde-3-phosphate Dehydrogenase (GAPDH)
Sample-12 C19D, C20D, C21D Pyruvate Kinase (PKM)
Sample-13 C19E, C20E, C21E Glyceraldehyde-3-phosphate Dehydrogenase (GAPDH)
Sample-14 C14O, C14P Fatty Acid Synthase (FASN)
Sample-15 C21P Fatty Acid Synthase (FASN)
  1. *The location of each protein on the 2-D gel was defined by two parameters: the serum group and the location on the 384-plate. 1. The serum group is represented by the first letter, N represents Normal Serum, and C represents Cancer Serum. For example, N19A represents sample from Normal Serum and the PEP plate well 19A